211 related articles for article (PubMed ID: 16475813)
1. Structural model of the BCL-w-BID peptide complex and its interactions with phospholipid micelles.
Denisov AY; Chen G; Sprules T; Moldoveanu T; Beauparlant P; Gehring K
Biochemistry; 2006 Feb; 45(7):2250-6. PubMed ID: 16475813
[TBL] [Abstract][Full Text] [Related]
2. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members.
Santiveri CM; Sborgi L; de Alba E
J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964
[TBL] [Abstract][Full Text] [Related]
3. Membrane-insertion fragments of Bcl-xL, Bax, and Bid.
García-Sáez AJ; Mingarro I; Pérez-Payá E; Salgado J
Biochemistry; 2004 Aug; 43(34):10930-43. PubMed ID: 15323553
[TBL] [Abstract][Full Text] [Related]
4. Unique structural features of a BCL-2 family protein CED-9 and biophysical characterization of CED-9/EGL-1 interactions.
Woo JS; Jung JS; Ha NC; Shin J; Kim KH; Lee W; Oh BH
Cell Death Differ; 2003 Dec; 10(12):1310-9. PubMed ID: 12894216
[TBL] [Abstract][Full Text] [Related]
5. Proapoptotic BH3-only protein Bid is essential for death receptor-induced apoptosis of pancreatic beta-cells.
McKenzie MD; Carrington EM; Kaufmann T; Strasser A; Huang DC; Kay TW; Allison J; Thomas HE
Diabetes; 2008 May; 57(5):1284-92. PubMed ID: 18252892
[TBL] [Abstract][Full Text] [Related]
6. Bid: a Bax-like BH3 protein.
Billen LP; Shamas-Din A; Andrews DW
Oncogene; 2008 Dec; 27 Suppl 1():S93-104. PubMed ID: 19641510
[TBL] [Abstract][Full Text] [Related]
7. Heat-induced dimerization of BCL-xL through alpha-helix swapping.
Denisov AY; Sprules T; Fraser J; Kozlov G; Gehring K
Biochemistry; 2007 Jan; 46(3):734-40. PubMed ID: 17223694
[TBL] [Abstract][Full Text] [Related]
8. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL.
Yin H; Lee GI; Sedey KA; Kutzki O; Park HS; Orner BP; Ernst JT; Wang HG; Sebti SM; Hamilton AD
J Am Chem Soc; 2005 Jul; 127(29):10191-6. PubMed ID: 16028929
[TBL] [Abstract][Full Text] [Related]
9. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
[TBL] [Abstract][Full Text] [Related]
10. A conserved hydrophobic core at Bcl-xL mediates its structural stability and binding affinity with BH3-domain peptide of pro-apoptotic protein.
Feng Y; Zhang L; Hu T; Shen X; Ding J; Chen K; Jiang H; Liu D
Arch Biochem Biophys; 2009 Apr; 484(1):46-54. PubMed ID: 19161970
[TBL] [Abstract][Full Text] [Related]
11. Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft.
Zhang YH; Bhunia A; Wan KF; Lee MC; Chan SL; Yu VC; Mok YK
J Mol Biol; 2006 Dec; 364(3):536-49. PubMed ID: 17011577
[TBL] [Abstract][Full Text] [Related]
12. Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis.
Rajan S; Choi M; Baek K; Yoon HS
Proteins; 2015 Jul; 83(7):1262-72. PubMed ID: 25907960
[TBL] [Abstract][Full Text] [Related]
13. Structural plasticity underpins promiscuous binding of the prosurvival protein A1.
Smits C; Czabotar PE; Hinds MG; Day CL
Structure; 2008 May; 16(5):818-29. PubMed ID: 18462686
[TBL] [Abstract][Full Text] [Related]
14. Interaction of a putative BH3 domain of clusterin with anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
Lee DH; Ha JH; Kim Y; Bae KH; Park JY; Choi WS; Yoon HS; Park SG; Park BC; Yi GS; Chi SW
Biochem Biophys Res Commun; 2011 May; 408(4):541-7. PubMed ID: 21527247
[TBL] [Abstract][Full Text] [Related]
15. BH3 peptidomimetics potently activate apoptosis and demonstrate single agent efficacy in neuroblastoma.
Goldsmith KC; Liu X; Dam V; Morgan BT; Shabbout M; Cnaan A; Letai A; Korsmeyer SJ; Hogarty MD
Oncogene; 2006 Aug; 25(33):4525-33. PubMed ID: 16568093
[TBL] [Abstract][Full Text] [Related]
16. Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1.
Day CL; Smits C; Fan FC; Lee EF; Fairlie WD; Hinds MG
J Mol Biol; 2008 Jul; 380(5):958-71. PubMed ID: 18589438
[TBL] [Abstract][Full Text] [Related]
17. Terephthalamide derivatives as mimetics of helical peptides: disruption of the Bcl-x(L)/Bak interaction.
Yin H; Lee GI; Sedey KA; Rodriguez JM; Wang HG; Sebti SM; Hamilton AD
J Am Chem Soc; 2005 Apr; 127(15):5463-8. PubMed ID: 15826183
[TBL] [Abstract][Full Text] [Related]
18. Photocontrollable peptide-based switches target the anti-apoptotic protein Bcl-xL.
Kneissl S; Loveridge EJ; Williams C; Crump MP; Allemann RK
Chembiochem; 2008 Dec; 9(18):3046-54. PubMed ID: 19012295
[TBL] [Abstract][Full Text] [Related]
19. Bid, a BH3-only multi-functional molecule, is at the cross road of life and death.
Yin XM
Gene; 2006 Mar; 369():7-19. PubMed ID: 16446060
[TBL] [Abstract][Full Text] [Related]
20. Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity.
Wilson-Annan J; O'Reilly LA; Crawford SA; Hausmann G; Beaumont JG; Parma LP; Chen L; Lackmann M; Lithgow T; Hinds MG; Day CL; Adams JM; Huang DC
J Cell Biol; 2003 Sep; 162(5):877-87. PubMed ID: 12952938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
